H5N1-SeroDetect EIA and rapid test: A novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12455-12463

  Khurana, Surender ^a   Sasono, Pretty ^b   Fox, Annette ^c   Van Kinh, Nguyen ^d   Mai, Le Quynh ^e   Thai, Pham Quang ^e   Hien, Nguyen Tran ^e   Liem, Nguyen Thanh ^f   Horby, Peter ^c   Golding, Hana ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d National Hospital of Tropical Diseases   (Viet Nam)

^e NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^f NATIONAL HOSPITAL OF PEDIATRICS   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CLADISTICS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FRAGMENT PHAGE DISPLAY LIBRARY; HUMAN; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MALE; PHAGE DISPLAY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SERODIAGNOSIS; UNITED STATES; VIET NAM; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIRAL PROTEINS; YOUNG ADULT;

AVES; ORTHOMYXOVIRIDAE;

EID: 81255164776     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06023-11     Document Type: Article

References (29)

1. Beigel, J. H., J. Voell, C. Y. Huang, P. D. Burbelo, and H. C. Lane. 2009. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J. Infect. Dis. 200:501-509.
2. Black, R. A., P. A. Rota, N. Gorodkova, H. D. Klenk, and A. P. Kendal. 1993. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J. Gen. Virol. 74:143-146.
3. Bouma, A., et al. 2009. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathog. 5:e1000281.
4. Chanturiya, A. N., et al. 2004. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 78:6304-6312.
5. Chen, H., et al. 2006. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl. Acad. Sci. U. S. A. 103:2845-2850.
6. Conenello, G. M., D. Zamarin, L. A. Perrone, T. Tumpey, and P. Palese. 2007. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3:1414-1421.
7. Cui, S., C. Chen, and G. Tong. 2008. A simple and rapid immunochromatographic strip test for monitoring antibodies to H5 subtype avian influenza virus. J. Virol. Methods 152:102-105.
8. Cui, S., and G. Tong. 2008. A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J. Vet. Diagn. Invest. 20:567-571.
9. de Jong, M. D., et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207.
10. Gambotto, A., S. M. Barratt-Boyes, M. D. de Jong, G. Neumann, and Y. Kawaoka. 2008. Human infection with highly pathogenic H5N1 influenza virus. Lancet 371:1464-1475.
11. Gerhard, W., K. Mozdzanowska, and D. Zharikova. 2006. Prospects for universal influenza virus vaccine. Emerg. Infect. Dis. 12:569-574.
12. Katz, J. M., et al. 1999. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J. Infect. Dis. 180:1763-1770.
13. Khurana, S., et al. 2006. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. J. Virol. 80:2092-2099.
14. Khurana, S., et al. 2010. HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J. Clin. Microbiol. 48:281-285.
15. Khurana, S., et al. 2009. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 6:e1000049.
16. Li, F. C., B. C. Choi, T. Sly, and A. W. Pak. 2008. Finding the real casefatality rate of H5N1 avian influenza. J. Epidemiol. Community Health 62:555-559.
17. Lu, H., et al. 2011. A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells. PLoS One 6:e17297.
18. Poetri, O. N., et al. 2009. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Vaccine 27:2864-2869.
19. Prabakaran, M., et al. 2009. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One 4:e4566.
20. Rowe, T., et al. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
21. Sakai-Tagawa, Y., et al. 2010. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J. Clin. Microbiol. 48:2872-2877.
22. Simonsen, L., R. J. Taylor, C. Viboud, M. A. Miller, and L. A. Jackson. 2007. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 7:658-666.
23. Smith, G. J., et al. 2006. Emergence and predominance of an H5N1 influenza variant in China. Proc. Natl. Acad. Sci. U. S. A. 103:16936-16941.
24. Smith, G. J., et al. 2006. Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam. Virology 350:258-268.
25. Stelzer-Braid, S., et al. 2008. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies. J. Clin. Virol. 43:241-243.
26. Tang, X. C., et al. 2006. Prevalence and genetic diversity of coronaviruses in bats from China. J. Virol. 80:7481-7490.
27. Vareckova, E., V. Mucha, F. Kostolansky, L. V. Gubareva, and A. Klimov. 2008. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes. Virus Res. 132:181-186.
28. Xu, K. M., et al. 2007. Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J. Virol. 81:2635-2645.
29. Zamarin, D., M. B. Ortigoza, and P. Palese. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 80:7976-7983.